Teplizumab licensed for use by adults and older children in ‘breakthrough moment’
Teplizumab licensed for use by adults and older children in ‘breakthrough moment’
Copy link
Teplizumab can allow patients to live “normal lives” without the need for insulin injections
The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start…
Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an…
Product aims to disrupt the autoimmune attack against insulin-producing beta cells
Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for…
The FDA has granted accelerated approval for teplizumab-mzwv as the first disease-modifying therapy for children and adolescents…
